|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
6217658 |
| 003 |
ICU |
| 005 |
20071017153600.0 |
| 008 |
060125s2006 nyu b 001 0deng |
| 010 |
|
|
|a 2006002543
|
| 015 |
|
|
|a GBA621113
|2 bnb
|
| 016 |
7 |
|
|a 013397357
|2 Uk
|
| 020 |
|
|
|a 0521864550 (hardback)
|
| 020 |
|
|
|a 9780521864558 (hardback)
|
| 020 |
|
|
|a 0521683831 (pbk.)
|
| 020 |
|
|
|a 9780521683838 (pbk.)
|
| 024 |
3 |
|
|a 9780521864558
|
| 024 |
3 |
|
|a 9780521683838
|
| 040 |
|
|
|a DLC
|c DLC
|d YDXCP
|d UKM
|d BAKER
|d COO
|d IG#
|d OCLCQ
|d BTCTA
|d UtOrBLW
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a CGUA
|
| 050 |
0 |
0 |
|a HD9666.9.M4
|b V34 2006
|
| 082 |
0 |
0 |
|a 338.7/616151092
|a B
|2 22
|
| 100 |
1 |
|
|a Vagelos, P. Roy.
|0 http://id.loc.gov/authorities/names/n93800256
|1 http://viaf.org/viaf/79536676
|
| 245 |
1 |
4 |
|a The moral corporation--Merck experiences /
|c P. Roy Vagelos, Louis Galambos.
|
| 260 |
|
|
|a New York :
|b Cambridge University Press,
|c 2006.
|
| 300 |
|
|
|a ix, 185 p. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 500 |
|
|
|a Includes index.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t The puzzle --
|g 2.
|t The professional path --
|g 3.
|t Turn around --
|g 4.
|t New drugs and public safety --
|g 5.
|t Corporate grooming --
|g 6.
|t Winning in global competition --
|g 7.
|t Prices and the public interest --
|g 8.
|t Moral leadership --
|g 9.
|t Afterwards.
|
| 610 |
2 |
0 |
|a Merck & Co.
|x Management.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|x Moral and ethical aspects
|z United States.
|
| 600 |
1 |
0 |
|a Vagelos, P. Roy.
|0 http://id.loc.gov/authorities/names/n93800256
|1 http://viaf.org/viaf/79536676
|
| 650 |
|
0 |
|a Business ethics.
|0 http://id.loc.gov/authorities/subjects/sh85018297
|
| 650 |
|
0 |
|a Social responsibility of business.
|0 http://id.loc.gov/authorities/subjects/sh90005735
|
| 600 |
1 |
7 |
|a Vagelos, P. Roy.
|2 fast
|0 http://id.worldcat.org/fast/fst00322865
|0 http://id.worldcat.org/fast/322865
|1 http://viaf.org/viaf/79536676
|
| 610 |
2 |
7 |
|a Merck & Co.
|2 fast
|0 http://id.worldcat.org/fast/fst00559439
|0 http://id.worldcat.org/fast/559439
|
| 650 |
|
7 |
|a Business ethics.
|2 fast
|0 http://id.worldcat.org/fast/fst00842675
|
| 650 |
|
7 |
|a Management.
|2 fast
|0 http://id.worldcat.org/fast/fst01007141
|
| 650 |
|
7 |
|a Pharmaceutical industry
|x Moral and ethical aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst01060163
|
| 650 |
|
7 |
|a Social responsibility of business.
|2 fast
|0 http://id.worldcat.org/fast/fst01122851
|
| 651 |
|
7 |
|a United States.
|2 fast
|0 http://id.worldcat.org/fast/fst01204155
|
| 700 |
1 |
|
|a Galambos, Louis.
|0 http://id.loc.gov/authorities/names/n82054860
|1 http://viaf.org/viaf/66503725
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)63179037
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 3ada9861-6fb6-5a1c-b02c-309303aa1192
|s f4caf8b0-6c26-5139-be53-a0fcab24f7b6
|
| 928 |
|
|
|t Library of Congress classification
|a HD9666.9.M4V34 2006
|l JRL
|c JRL-Gen
|i 5327228
|
| 927 |
|
|
|t Library of Congress classification
|a HD9666.9.M4V34 2006
|l JRL
|c JRL-Gen
|e PRSO
|b 75672192
|i 8117501
|
